InnovAge
INNV
#5979
Rank
NZ$1.70 B
Marketcap
NZ$12.53
Share price
-3.98%
Change (1 day)
112.22%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2025 (TTM): -NZ$36.61 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$0.88 Billion. In 2024 the company made an earning of -NZ$43.82 Million, an increase over its 2023 earnings that were of -NZ$58.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$36.61 Million-16.46%
2024 -NZ$43.82 Million-24.58%
2023 -NZ$58.1 Million-31.82%
2022 -NZ$85.22 Million-681.94%
2021 NZ$14.64 M-388.91%
2020 -NZ$5.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$38.74 B-111,088.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-NZ$16.39 Million-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.26 Million-50.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.85 B-2,563.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland